IL-12 deficiency suppresses 12- O -tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz( a )anthracene-initiated mouse skin through inhibition of inflammation
Authors:
Open Access
- 16 September 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 30 (11) , 1970-1977
Abstract
Interleukin (IL)-12 deficiency exacerbates tumorigenesis in ultraviolet (UV) radiation-induced skin. Here, we assessed the effects of IL-12 deficiency on 12- O -tetradecanoylphorbol-13-acetate (TPA)-induced tumor promotion in 7,12-dimethylbenz( a )anthracene (DMBA)-initiated mouse skin. Using this two-stage chemical carcinogenesis protocol, we found that the development of DMBA/TPA-induced skin tumors was diminished in IL-12p40-knockout mice than in their wild-type counterparts. At the termination of the experiment (at 24 weeks), the skin tumor incidence and tumor multiplicity were significantly lower ( P < 0.005) in interleukin-12-knockout (IL-12 KO) mice than in their wild-type counterparts, as was the malignant transformation of DMBA/TPA-induced papillomas to carcinomas ( P < 0.01). Analysis of samples collected at the termination of the experiments for biomarkers of inflammation by immunohistochemical analysis, western blotting, enzyme-linked immunosorbent assay and real-time polymerase chain reaction revealed significantly lower levels of cyclooxygenase-2 (COX-2), prostaglandin (PG) E 2 , proliferating cell nuclear antigen, cyclin D1 and the proinflammatory cytokines (tumor necrosis factor-α, IL-1β and IL-6) in the DMBA/TPA-treated tumors and tumor-uninvolved skin of IL-12 KO mice than the skin and tumors of DMBA/TPA-treated wild-type mice. Analysis of the skin 6 h after TPA treatment showed that the TPA-induced promotion of skin edema, inflammatory leukocyte infiltration, COX-2 expression and PGE 2 production was significantly lower in the skin of the IL-12-KO mice than their wild-type counterparts. These results indicate that DMBA/TPA-induced skin tumor development differs from UVB-induced skin tumor development in that endogenous IL-12 acts to inhibit UVB-induced skin tumor development and malignant progression of the skin tumors to carcinoma. In the case of DMBA/TPA-induced skin tumor development, the endogenous IL-12 modulates the tumor promoter stimulation of inflammatory responses.Keywords
This publication has 44 references indexed in Scilit:
- Inhibition of UVB-Induced Skin Tumor Development by Drinking Green Tea Polyphenols Is Mediated Through DNA Repair and Subsequent Inhibition of InflammationJournal of Investigative Dermatology, 2009
- IL-12 p40 homodimer, but not IL-12 p70, induces the expression of IL-16 in microglia and macrophagesMolecular Immunology, 2009
- RETRACTED: IL-12 Deficiency Exacerbates Inflammatory Responses in UV-Irradiated Skin and Skin TumorsJournal of Investigative Dermatology, 2008
- Interleukin-12 Deficiency Is Permissive for Angiogenesis in UV Radiation-Induced Skin TumorsCancer Research, 2007
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenolsCarcinogenesis, 1997
- Photocarcinogenesis: Mechanisms, Models and Human Health Implications: IntroductionPhotochemistry and Photobiology, 1996
- Epidermal Interleukin-1 is Increased in Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 1988
- Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth patternArchives of Dermatology, 1986